Predict your next investment

HEALTHCARE | Pharmaceuticals / Drugs
jingmedicine.com

See what CB Insights has to offer

Stage

Series A | Alive

Total Raised

$20M

Last Raised

$20M | 4 yrs ago

About Jing Medicine Technology (Shanghai) Ltd.

Developer of therapeutic monoclonal antibody and small molecule drugs for oncology, immunology, and neurology. The company offers small molecule drugs. The business features a bacteriophage database and protein degradation technology.

Jing Medicine Technology (Shanghai) Ltd. Headquarter Location

99 Haike Road Building 6, 1st Floor

Shanghai, Shanghai, 201203,

China

86 21 60352900

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Research containing Jing Medicine Technology (Shanghai) Ltd.

Get data-driven expert analysis from the CB Insights Intelligence Unit.

CB Insights Intelligence Analysts have mentioned Jing Medicine Technology (Shanghai) Ltd. in 18 CB Insights research briefs, most recently on Jul 21, 2021.

Expert Collections containing Jing Medicine Technology (Shanghai) Ltd.

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Jing Medicine Technology (Shanghai) Ltd. is included in 1 Expert Collection, including Biopharmaceuticals.

B

Biopharmaceuticals

5,731 items

Companies involved in the research, development, and commercialization of chemically- or biologically-derived therapeutic & theranostic drugs. Excludes vitamins/supplements, CROs/clinical trial services.

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.